TargImmune Therapeutics

Pre-clinical

Basel, SwitzerlandFounded 2016targimmune.com

At TargImmune our mission is to significantly improve survival of cancer patients.

Market Cap

Private

Pipeline

—

Patents

—

Publications

—

Private Company

Total funding raised: $20M

At TargImmune our mission is to significantly improve survival of cancer patients.

Small Molecules

Total raised:$20M

Series A$20MUndisclosedNov 15, 2021